Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Non-malignant Disease
Do you counsel patients differently about the risk of radiation induced malignancy when you are treating a proximal joint (hip) vs a distal joint (elbow) for benign conditions such as OA?
Related Questions
Would you re-RT for heterotopic ossification if the first course of postoperative radiation failed to prevent HO formation?
For those treating osteoarthritis with LDRT, is there any concern of adverse effects or decreased efficacy in patients with osteoporosis?
What fractionation would you use for a young patient with a schwannoma that has regrown within 2 years of resection?
Would you offer re-irradiation LDRT for someone with osteoarthritis or tendinitis if symptoms recur?
How do you approach counseling patients on the use of low-dose radiation therapy for osteoarthritis who are concurrently receiving parathyroid hormone anabolic treatment?
When do you treat heterotopic ossification with radiation pre-operatively?
Do you routinely obtain a biopsy of a presumed meningioma prior to SRS to confirm grade 1?
Do you offer low-dose radiation therapy for osteoarthritis of the spine?
Is it appropriate to consider ultra-hypofractionation for phyllodes tumors of the breast when adjuvant radiotherapy is indicated?
How do you approach radiation treatment of extramammary Paget's disease of vulva, diffusely involving the urothelium and the periurethral glands?
